Wolfgang Miesbach on Frailty in Hemophilia: New Data Shows 3x Higher Risk
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a proud post on Linkedin:
“Frailty in Haemophilia: A Hidden Challenge for Aging Patients.
New research reveals a concerning trend: People with haemophilia (PWH) face significantly higher rates of frailty compared to the general population—nearly 3x higher in those over 65.
Alarming frailty rates:
PWH aged 50-64: 17% have frailty vs. expected ~5%
PWH aged ≥65: 29% have frailty vs. 10% general population
This means PWH are aging like they’re 15+ years older
The ‘premature aging’ effect:
30% annual fall rate in PWH (~age 40)
Equivalent to general population >75 years
58% experience polypharmacy vs 45% in peers
The Geriatric Topics Affecting PWH:
- Falls and Immobility – chronic joint damage creates mechanical instability
- Cognitive Concerns – potential links to cerebral microbleeds under investigation
- Functional Incontinence – arthropathy limits timely toilet access
- Medication Overload – complex regimens for multiple conditions
Clinical Game-Changers:
- Clinical Frailty Scale screening to be recommended for all PWH >50
- Comprehensive Geriatric Assessment proven to reverse/slow frailty
- Novel care pathways needed: physiotherapy, occupational therapy, pharmacy optimization
This research highlights the urgent need for age-appropriate care pathways in haemophilia treatment centers. As our PWH population lives longer thanks to better treatments, we must address the unique challenges of aging with a bleeding disorder.”
Amazing review by Wolfgang Miesbach, read the full article here.
Title: Frailty and frailty syndromes in persons with haemophilia: a review
Authors: William McKeown, Stephanie Taylor, Susan Shapiro
Stay informed with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS